CD36 and neoplasm: Genetic ablation of CD36 in Treg cells suppressed tumor growth accompanied by enhancement of antitumor activity in tumor-infiltrating lymphocytes, and a decrease in intratumoral Treg cells without disrupting immune homeostasis.